Funding
Future of Health Grant Level 3 support · Healthtech

Prevision Medicine selected for Future of Health Grant Level 3

PrevisionOne measures drug responses in living patient cells to support cancer-treatment decisions.

By RoundOS Funding desk

Prevision Medicine was selected for Level 3 in the Future of Health Grant’s Fall 2026 cohort, announced on September 7.

The Zurich company tests patient cancer cells against more than 100 drugs and combinations. Automated microscopy tracks cellular responses, producing a report for the treating oncologist. The workflow adds direct functional testing to other information used when comparing treatment options.

Funding history

Future of Health Grant Level 3 support · This roundUndisclosed
Future of Health Grant Level 2 supportUndisclosed

Sources

  1. Future of Health Grant historical programme announcementfuture-of-health.org · Sep 7, 2026
  2. Prevision Medicine official product descriptionprevisionmedicine.com

Similar rounds

All Healthtech rounds →
LIFESCAPES

Japanese developer of brain-machine interface rehabilitation devices for people with impaired hand movement.

UndisclosedFollow-on equity investment · Oct 30, 2026
Jagruti Rehabilitation Centre

Jagruti Rehabilitation Centre operates residential facilities for mental healthcare, addiction treatment and dementia care across India.

₹280MSeries A · Oct 29, 2026
Docterz

Docterz provides clinic software for patient records, appointments, billing, vaccination management and communication between doctors and patients.

₹50MUndisclosed · Oct 29, 2026
Magic Vision

Magic Vision develops AI monitoring technology that helps care providers and families respond to falls and changes in daily activity.

€600KFunding round · Oct 28, 2026

Related